245 - Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (LR-MDS)

Autor: Gerds, A.T., Gupta, S., Sekeres, M.A., Nazha, A., Carraway, H.E., Hawthorne, S., King-Concialdi, K., McGuire, M.
Zdroj: In Leukemia Research April 2017 55 Supplement 1:S140-S141
Databáze: ScienceDirect